Recovery and remission in schizophrenia: Results from a naturalistic 2-year follow-up inpatient study;Recovery und Remission bei Schizophrenie: Ergebnisse einer naturalistischen 2-Jahres-Katamnesestudie ehemals stationärer Patienten

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 8, 2010, Pages 468-474

  Wolter, A ^a   Preuss U ^b   Krischke, N ^c   Wong, J W ^b   Langosch, J M ^a   Zimmermann, J ^d  

^a Krankenhaus Bethanien   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d Allgemeinpsychiatrie   (Germany)

Author keywords

Follow up; Quality of life; Recovery; Remission; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CONVALESCENCE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; REMISSION; SCHIZOPHRENIA; SOCIAL INTERACTION;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RECOVERY OF FUNCTION; REMISSION, SPONTANEOUS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77955689939     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245495     Document Type: Article

References (29)

1. Association A P. DSM-III: Diagnostic and Statistical Manual of Mental Disorders. 3. Aufl. Washington, DC American Psychiatric Association 1980
2. McGlashan T. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 1988 14 515-540
3. Jobe T, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry 2005 50 892-900
4. Harrison G, Hopper K, Craig T et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001 178 506-517
5. Færden A, Nesv̊g R, Marder S. Definitions of the term recovered in schizophrenia and other disorders. Psychopathology 2008 41 271-278
6. Leucht S, Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006 39 161-170
7. Andreasen N, Carpenter W, Kane J et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005 162 441-449
8. Weiden P, Zygmunt A. Medication noncompliance in schizophrenia. Part I. Assessment. J Prac Psychiatry Behav Health 1997 3 106-110
9. Bellack A. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull 2006 32 432-442
10. Davidson L, Schmutte T, Dinzeo T et al. Remission and recovery in schizophrenia: practicioner and patient perspectives. Schizophr Bull 2008 34 5-8
11. Liberman R, Kopelowicz A, Ventura J et al. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry 2002 14 256-272
12. Lauronen E, Koskinen J, Veijola J et al. Recovery from schizophrenic psychoses within the Northern Finland 1966 Birth Cohort. J Clin Psychiatry 2005 66 375-383 (Pubitemid 40476762)
13. Lambert M, Schimmelmann B, Naber D et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006 67 1690-1697
14. Strauss J, Carpenter W. The prediction of outcome in schizophrenia: II. Relationships between predictor and outcome variables: a report from the WHO International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1974 31 37-42
15. Harding C, Brooks G, Ashikiga T et al. The Vermont longitudinal study of persons with severe mental illness: I. Methodology, study sample, and overall status 32 years later. Am J Psychiatry 1987 144 718-726
16. Naber D, Lambert M, Laux G et al. Remission patientenorientiertes Kriterium für nachhaltigen Erfolg in der Schizophrenietherapie. Psychopharmakotherapie 2007 14 143-148
17. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep 1962 10 799-812
18. Kay S, Opler L, Lindenmayer J. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989 7 S59-S67
19. Association AP. Diagnostic and Statistical Manual of Mental Disorders. 4th. edition Aufl. Washington, DC American Psychiatric Press 1996
20. Naber D. Subjektives Wohlbefinden unter Neuroleptika (Lang- und Kurzform). in Schumacher J Klaiberg A Brähler E Editors Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Göttingen Hogrefe 2003
21. Bachmann S, Bottmer C, Schröder J. One-year outcome and its prediction in first-episode schizophrenia a naturalistic study. Psychopathology 2008 41 115-123
22. Lambert M, Naber D, Eich F et al. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007 115 106-113
23. Angermeyer M, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF. Handbuch für die deutschsprachige Version der WHO-Instrumente zur Erfassung von Lebensqualität. Göttingen Hogrefe 2000
24. Breier A, Schreiber J, Dyer J et al. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome in schizophrenia. Arch Gen Psychiatry 1991 48 239-246
25. Gupta S, Andreasen N, Arndt S et al. The Iowa longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients. Br J Psychiatry 1994 23 1-13
26. Wolter A, Preuss U, Krischke N et al. Remission, prediction and stability of symptoms in schizophrenia a naturalistic 12-month follow-up study. Int J Psychiatr Clin Pract 2009 accepted
27. Zimmermann J, Wolter A, Hannöver W et al. Remissionshäufigkeit bei schizophren erkrankten Patienten innerhalb eines Jahres nach der Klinikentlassung. Psychiat Prax 2008
28. Cohen P, Cohen J. The clinicians illusion. Arch Gen Psychiatry 1984 41 1178-1182
29. McGlashan T. The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry 1984 41 586-601